ZBIO – zenas biopharma, inc. (US:NASDAQ)
Stock Stats
News
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch [Yahoo! Finance]
Zenas BioPharma (ZBIO) was downgraded by Wall Street Zen from "hold"
Zenas BioPharma (ZBIO) was downgraded by Zacks Research from "hold" to "strong sell".
Zenas BioPharma (ZBIO) had its price target lowered by Citigroup Inc. from $43.00 to $41.00. They now have a "buy" rating on the stock.
Form 424B5 Zenas BioPharma, Inc.
Form 424B5 Zenas BioPharma, Inc.
Form FWP Zenas BioPharma, Inc. Filed by: Zenas BioPharma, Inc.
Form DEFA14A Zenas BioPharma, Inc.
Form ARS Zenas BioPharma, Inc. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.